Comparison of dipeptidyl peptidase-4 inhibitors and pioglitazone combination therapy versus pioglitazone monotherapy in type 2 diabetes: A system review and meta-analysis (Q60054208)
Jump to navigation
Jump to search
No description defined
Language | Label | Description | Also known as |
---|---|---|---|
English | Comparison of dipeptidyl peptidase-4 inhibitors and pioglitazone combination therapy versus pioglitazone monotherapy in type 2 diabetes: A system review and meta-analysis |
No description defined |
Statements
7 references
13 March 2019
14 March 2019
Comparison of dipeptidyl peptidase-4 inhibitors and pioglitazone combination therapy versus pioglitazone monotherapy in type 2 diabetes: A system review and meta-analysis (English)
0 references
November 2018
0 references
1 November 2018
7 references
13 March 2019
14 March 2019
24 March 2019
2 August 2019
2 October 2019
30 January 2021
4 February 2021
7 references
13 March 2019
14 March 2019
24 March 2019
2 August 2019
2 October 2019
30 January 2021
4 February 2021
97
0 references
e12633
0 references
46
0 references
7 references
13 March 2019
14 March 2019
24 March 2019
2 August 2019
2 October 2019
30 January 2021
4 February 2021
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference